H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways

Susan H Kwon1, David R Pimentel, Andrea Remondino

  • 1Myocardial Biology Unit and Cardiovascular Division, Boston University Medical Center, and School of Medicine, 88 East Newton Street, MA 02118, Boston, USA.

Insights

Reactive oxygen species (ROS) trigger cardiac myocyte hypertrophy or apoptosis based on concentration. Differential kinase pathway activation explains these ROS effects, revealing distinct signaling for growth versus cell death.

Area of Science:

  • Cardiovascular Biology
  • Cell Signaling
  • Oxidative Stress

Background:

  • Reactive oxygen species (ROS) are crucial signaling molecules in cardiac myocytes.
  • ROS can induce either cardiac myocyte hypertrophy (growth) or apoptosis (programmed cell death).

Purpose of the Study:

  • To investigate if concentration-dependent ROS effects on cardiac myocytes are mediated by specific kinase signaling pathways.
  • To elucidate the role of differential kinase activation in ROS-induced hypertrophy and apoptosis.

Main Methods:

  • Adult rat ventricular myocytes were treated with hydrogen peroxide (H2O2) across a wide concentration range (10-1000 microM).
  • Kinase activity (ERK1/2, JNK, p38, Akt) was measured.
  • Specific inhibitors (U0126, dominant-negative JNK, Akt inhibitor) were used to block signaling pathways.

Main Results:

  • Low H2O2 concentrations (10-30 microM) promoted protein synthesis (hypertrophy) via ERK1/2 activation.
  • Higher H2O2 concentrations (100-200 microM) induced apoptosis through JNK, p38, and Akt activation.
  • Inhibitor studies confirmed the roles of ERK1/2 in hypertrophy and JNK/p38/Akt in apoptosis.

Conclusions:

  • ROS exert concentration-dependent effects on cardiac myocytes, driving either hypertrophy or apoptosis.
  • Differential activation of specific kinase pathways (ERK1/2, JNK, p38, Akt) underlies these distinct cellular responses.
  • Targeting these kinase pathways could modulate ROS-induced cardiac myocyte remodeling.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...